141 related articles for article (PubMed ID: 9712459)
1. Monitoring of tacrolimus as rescue therapy in pediatric liver transplantation.
Moreno M; Manzanares C; Castellano F; Medina E; Urruzuno P; Camarena C; Manzanares J; Jara P
Ther Drug Monit; 1998 Aug; 20(4):376-9. PubMed ID: 9712459
[TBL] [Abstract][Full Text] [Related]
2. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
3. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
[TBL] [Abstract][Full Text] [Related]
4. Long-term results after conversion from cyclosporine to tacrolimus in pediatric liver transplantation for acute and chronic rejection.
Reyes J; Jain A; Mazariegos G; Kashyap R; Green M; Iurlano K; Fung J
Transplantation; 2000 Jun; 69(12):2573-80. PubMed ID: 10910279
[TBL] [Abstract][Full Text] [Related]
5. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
Yoshida EM; Lilly LB; Marotta PJ; Mason AL; Bilodeau M; Vaillancourt M
Ann Hepatol; 2013; 12(2):282-93. PubMed ID: 23396740
[TBL] [Abstract][Full Text] [Related]
6. REFINE: a randomized trial comparing cyclosporine A and tacrolimus on fibrosis after liver transplantation for hepatitis C.
Levy G; Villamil FG; Nevens F; Metselaar HJ; Clavien PA; Klintmalm G; Jones R; Migliaccio M; Prestele H; Orsenigo R;
Am J Transplant; 2014 Mar; 14(3):635-46. PubMed ID: 24456049
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
8. Conversion to rescue therapy with FK 506: data from eight liver transplant patients.
Reggiani P; Orsenigo R; Gatti S; Albani AP; Ferla G; Doglia M; Fassati LR; Galmarini D
Transplant Proc; 1994 Dec; 26(6):3597-8. PubMed ID: 7527982
[No Abstract] [Full Text] [Related]
9. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
Guitard J; Sandres-Sauné K; Kamar N; Ribes D; Faguer S; Esposito L; Lavit M; Muscari F; Péron JM; Lavayssière L; Durand D; Rostaing L
Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
[TBL] [Abstract][Full Text] [Related]
10. Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.
Hedayat S; Kershner RP; Su G
J Biopharm Stat; 1996 Nov; 6(4):411-24. PubMed ID: 8969977
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection.
Kugelmas M; Osgood MJ; Trotter JF; Bak T; Wachs M; Forman L; Kam I; Everson GT
Liver Transpl; 2003 Nov; 9(11):1159-65. PubMed ID: 14586876
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic monitoring of tacrolimus in pediatric and adult transplanted patients.
Capone D; Gentile A; Vajro P; Stanziale P; Imperatore P; De Silva C; Pellegrino T; Basile V
J Chemother; 1998 Apr; 10(2):176-8. PubMed ID: 9603651
[No Abstract] [Full Text] [Related]
14. Rejection and tacrolimus conversion therapy in paediatric liver transplantation.
Spada M; Corno V; Colledan M; Segalin A; Lucianetti A; Torre G; Riva S; Sonzogni A; Petz W; Gridelli B
Transpl Int; 2000; 13 Suppl 1():S341-4. PubMed ID: 11112028
[TBL] [Abstract][Full Text] [Related]
15. Conversion from cyclosporine to tacrolimus in hepatic and renal transplantation.
Yussim A; Shaharabani E; Mor E; Lustig S; Bar-Nathan N; Shmueli D; Sobolev V; Dorfman B; Or H; Shapira Z
Transplant Proc; 1996 Dec; 28(6):3178-9. PubMed ID: 8962233
[No Abstract] [Full Text] [Related]
16. A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.
Shenoy S; Hardinger KL; Crippin J; Korenblat K; Lisker-Melman M; Lowell JA; Chapman W
Liver Transpl; 2008 Feb; 14(2):173-80. PubMed ID: 18236391
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic drug monitoring of tacrolimus in liver transplantation, phase III FK506 multicenter Spanish Study Group: a two-year follow-up.
Pou L; Brunet M; Bilbao I; Andreu H; Andres I; Lopez R; Margarit C; Rimola A; Corbella J
Ther Drug Monit; 1998 Dec; 20(6):602-6. PubMed ID: 9853973
[TBL] [Abstract][Full Text] [Related]
18. Role of steroid dose in hypertension early after liver transplantation with tacrolimus (FK506) and cyclosporine.
Taler SJ; Textor SC; Canzanello VJ; Schwartz L; Porayko M; Wiesner RH; Krom RA
Transplantation; 1996 Dec; 62(11):1588-92. PubMed ID: 8970613
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cyclosporine microemulsion and tacrolimus in 39 recipients of living donor liver transplantation.
Tanaka K; Lake J; Villamil F; Levy G; Marotta P; Mies S; de Hemptinne B; Moench C
Liver Transpl; 2005 Nov; 11(11):1395-402. PubMed ID: 16237691
[TBL] [Abstract][Full Text] [Related]
20. The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation.
Branco KC; Azeka E; Trindade E; Galas FR; Hajjar LA; Benvenuti L; Riso A; Tanamati C; Penha J; Auler JO; Jatene M
Transplant Proc; 2012 Oct; 44(8):2483-5. PubMed ID: 23026625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]